| Literature DB >> 28865783 |
Ramón C Hermida1, Diana E Ayala2, José R Fernández2, Artemio Mojón2, Juan J Crespo3, María T Ríos4, Michael H Smolensky5.
Abstract
Consistent evidence of numerous studies substantiates the asleep blood pressure (BP) mean derived from ambulatory BP monitoring (ABPM) is both an independent and a stronger predictor of cardiovascular disease (CVD) risk than are daytime clinic BP measurements or the ABPM-determined awake or 24-hour BP means. Hence, cost-effective adequate control of sleep-time BP is of marked clinical relevance. Ingestion time, according to circadian rhythms, of hypertension medications of 6 different classes and their combinations significantly improves BP control, particularly sleep-time BP, and reduces adverse effects.Entities:
Keywords: Ambulatory blood pressure monitoring; Asleep blood pressure; Cardiovascular risk; Chronic kidney disease; Diabetes; Hygia project; Hypertension chronotherapy; Resistant hypertension
Mesh:
Substances:
Year: 2017 PMID: 28865783 DOI: 10.1016/j.hfc.2017.05.010
Source DB: PubMed Journal: Heart Fail Clin ISSN: 1551-7136 Impact factor: 3.179